Staar Surgical Co
A maker of implantable lenses for the eye, STAAR Surgical is best known for its EVO ICL — a tiny, foldable lens surgically placed behind the iris to correct nearsightedness as an alternative to glasses, contacts, or LASIK. Founded in 1982 by Tom Waggoner and Dr. Thomas Mazzocco, the company pioneered the first foldable intraocular lens for cataract surgery. Its lenses are made from Collamer, a proprietary material whose name blends "collagen" and "polymer," helping the eye accept the implant as its own.
Bought 7.63M · Sold 1.93M
Bought 6.69M · Sold 60.0K
Granted 191.9K · Sold 217.6K
Granted 301.8K · Bought 35.0K · Sold 10.0K
Granted 614.9K · Bought 10.0K · Sold 466.2K
Granted 80.0K · Bought 5.0K · Sold 56.7K
Granted 85.1K · Bought 58.9K
Granted 375.9K · Sold 326.7K
Granted 99.0K
Granted 77.1K
Granted 92.5K
Granted 83.0K · Bought 15.0K · Sold 41.0K
Granted 15.0K
Granted 97.4K · Sold 7.6K
Granted 10.6K
Granted 28.1K · Bought 8.6K
Granted 298.8K · Sold 252.1K
Granted 205.2K · Sold 155.2K
Granted 63.8K
Granted 102.6K · Sold 1.6K
Granted 74.0K · Bought 50.0K · Sold 82.9K
Granted 96.8K · Sold 56.8K
Granted 21.7K · Sold 16.7K
Granted 55.5K
Granted 30.5K · Bought 8.0K · Sold 5.0K
Granted 40.8K
Granted 56.1K · Sold 40.9K
Granted 200.4K · Sold 203.4K
Granted 27.8K
Granted 186.3K · Bought 15.0K · Sold 140.1K
Granted 18.8K
Granted 18.3K · Bought 25.0K · Sold 25.0K
Granted 25.5K · Sold 5.0K
Granted 182.6K · Sold 187.6K
Granted 11.6K · Bought 3.8K
Granted 67.5K · Bought 1.5K · Sold 53.9K
Granted 355.6K · Sold 286.2K
Granted 10.5K
Granted 34.7K · Sold 17.9K
Granted 8.2K · Bought 1.3K
Granted 72.9K · Sold 88.5K
Granted 34.0K · Sold 17.8K
Granted 7.3K · Bought 850
Granted 22.0K · Sold 7.0K
Granted 6.1K
Granted 2.6K · Bought 2.5K
Granted 2.8K
Granted 1.2K · Bought 1.0K
| Insider | Stake change | Holds now | Granted / vested | Bought | Sold |
|---|---|---|---|---|---|
| Bradsher Neal C +2 co-filersDirector, 10% owner, 10% owner · 234 transactions | — | 72.38M | — | 7.63M | 1.93M |
| Bradsher Neal C +2 co-filers10% owner · 384 transactions | — | 21.41Mas of Jan 2021 | — | 6.69M | 60.0K |
| Bailey DavidPresident, Int'l Operations, Director · 158 transactions | — | 1.14Mas of Mar 2010 | 191.9K | — | 217.6K |
| Caldwell Barry GDirector · 16 transactions | — | 309.8Kas of Jun 2014 | 301.8K | 35.0K | 10.0K |
| Mason Caren LPresident & CEO, Director · 34 transactions | — | 152.4Kas of Jun 2022 | 614.9K | 10.0K | 466.2K |
| Curtis Nicholas TSr. VP Sales · 19 transactions | — | 113.0Kas of May 2008 | 80.0K | 5.0K | 56.7K |
| Bailey Don MDirector · 33 transactions | — | 98.1Kas of May 2013 | 85.1K | 58.9K | — |
| Blickensdoerfer Hans-MartinSr. VP, Comm. Ops, China · 48 transactions | — | 83.1Kas of Mar 2022 | 375.9K | — | 326.7K |
| Foust WarrenInterim Co-CEO and Pres. & COO · 15 transactions | — | 81.5K | 99.0K | — | — |
| Jiang WeiDirector · 6 transactions | — | 77.1K | 77.1K | — | — |
| Frinzi Thomas GPresident & CEO, Director · 8 transactions | — | 70.5Kas of Jan 2025 | 92.5K | — | — |
| Duffy DonaldDirector · 38 transactions | — | 57.0Kas of May 2012 | 83.0K | 15.0K | 41.0K |
| Subrin PhilippeVice President, Switzerland Op · 2 transactions | — | 56.5Kas of Mar 2013 | 15.0K | — | — |
| Williams Patrick F.Chief Financial Officer · 20 transactions | — | 56.2Kas of Mar 2025 | 97.4K | — | 7.6K |
| Studholme RobertSenior VP, Operations · 2 transactions | — | 53.3Kas of Mar 2023 | 10.6K | — | — |
| Logan Mark BDirector · 8 transactions | — | 46.7Kas of Jul 2015 | 28.1K | 8.6K | — |
| Gesten Samuel JChief Legal Officer · 42 transactions | — | 43.7Kas of Mar 2023 | 298.8K | — | 252.1K |
| Francese James ESr. VP, Comm. Ops., NA, APAC · 43 transactions | — | 42.7Kas of Mar 2023 | 205.2K | — | 155.2K |
| Michna MagdaChief Development Officer · 19 transactions | — | 42.2K | 63.8K | — | — |
| Barnes Scott DChief Medical Officer · 25 transactions | — | 41.5Kas of Mar 2023 | 102.6K | — | 1.6K |
| Hughes RobinVice President, R&D · 77 transactions | — | 41.1Kas of Apr 2015 | 74.0K | 50.0K | 82.9K |
| Morrison David RDirector · 26 transactions | — | 40.0Kas of Dec 2011 | 96.8K | — | 56.8K |
| Kamijo IsamuPresident, STAAR Japan Inc. · 3 transactions | — | 40.0Kas of Dec 2010 | 21.7K | — | 16.7K |
| Farrell Stephen CPresident & CEO, Director · 19 transactions | — | 35.2Kas of Mar 2025 | 55.5K | — | — |
| Kaufman Charles SV.P. , General Counsel · 10 transactions | — | 34.4Kas of Aug 2011 | 30.5K | 8.0K | 5.0K |
| Brown Stephen PVP, Chief Financial Officer · 6 transactions | — | 31.9Kas of Mar 2017 | 40.8K | — | — |
| Goodmen William WalterGlobal VP, Human Resources · 20 transactions | — | 31.7Kas of Aug 2012 | 56.1K | — | 40.9K |
| Holliday KeithChief Technology Officer · 45 transactions | — | 28.2Kas of Mar 2023 | 200.4K | — | 203.4K |
| Sisitsky NathanielChief Legal Officer · 4 transactions | — | 22.8K | 27.8K | — | — |
| Moore John CDirector · 33 transactions | — | 20.6Kas of Dec 2020 | 186.3K | 15.0K | 140.1K |
| Slacik Charles PDirector · 5 transactions | — | 18.8Kas of Jul 2015 | 18.8K | — | — |
| Meier Richard ADirector · 13 transactions | — | 18.3Kas of May 2016 | 18.3K | 25.0K | 25.0K |
| Wall William PDirector · 9 transactions | — | 16.5Kas of Dec 2019 | 25.5K | — | 5.0K |
| Hayashida Jon K.VP, Global Clinical, Medical · 26 transactions | — | 15.5Kas of May 2021 | 182.6K | — | 187.6K |
| Weisner Aimee SDirector · 6 transactions | — | 15.4Kas of Jun 2024 | 11.6K | 3.8K | — |
| Silverman LouDirector · 15 transactions | — | 11.2K | 67.5K | 1.5K | 53.9K |
| Andrews Deborah JInterim Co-CEO and CFO · 73 transactions | — | 10.5K | 355.6K | — | 286.2K |
| Kliman Gilbert HDirector · 8 transactions | — | 10.5Kas of Dec 2023 | 10.5K | — | — |
| Fagen Donald LV.P. Sales for N. America · 27 transactions | — | 9.8Kas of Mar 2012 | 34.7K | — | 17.9K |
| Butcher Arthur CDirector · 4 transactions | — | 9.5K | 8.2K | 1.3K | — |
| Hansen Graydon C.Sr. VP, Global Operations · 29 transactions | — | 9.2Kas of May 2021 | 72.9K | — | 88.5K |
| Felberg CraigVP, R&D and Clinical Affairs · 23 transactions | — | 8.7Kas of Jun 2012 | 34.0K | — | 17.8K |
| Zhou Lilian YanshengDirector · 4 transactions | — | 8.1K | 7.3K | 850 | — |
| Todd Donald JPresident, Asia/Pacific · 13 transactions | — | 7.5Kas of Jun 2012 | 22.0K | — | 7.0K |
| Tunstall KathrynDirector · 2 transactions | — | 6.1Kas of Jun 2014 | 6.1K | — | — |
| Lin Elizabeth YeuDirector · 3 transactions | — | 5.1Kas of Jun 2024 | 2.6K | 2.5K | — |
| Yu K PeonyDirector · 4 transactions | — | 2.8Kas of Jun 2023 | 2.8K | — | — |
| Roush Jack StevenDirector · 2 transactions | — | 1.0Kas of Aug 2015 | 1.2K | 1.0K | — |
Select a row to see that insider’s individual transactions. Sum of the holdings confirmed in the 12 months before this insider's last filing. A Form 4 reports a holding per line — held directly, or through a named trust, partnership or foundation, and in each share class separately — never a person’s total. Lines not restated in that time are left out and shown apart: an active filer restates what they still hold, so a line they did not restate is more often an entity since renamed, whose shares a successor line reports too. An amber marker means some were left out.
Net open-market activity over all recorded history: +9.81M shares. Grants, option exercises and tax withholding are excluded — they are compensation mechanics, not decisions to buy or sell.